Log in or Sign up for Free to view tailored content for your specialty!
Dermatology News
FDA approves IDP-126, first triple-combination gel for treatment of acne
The FDA has approved IDP-126 for the treatment of acne in patients aged 12 years and older, Bausch Health announced in a press release.
Vibrio cases, deaths in Florida doubled after Hurricane Ian
Vibrio cases and deaths in Florida spiked last year after Hurricane Ian, lending credence to concerns that larger, longer, warmer tropical storms may increase the risk for viral infections, according to a study.
Log in or Sign up for Free to view tailored content for your specialty!
Girl develops itching scalp, white material in hair
A healthy 7-year-old girl is sent to the school nurse by her teacher, who was concerned about the girl scratching her scalp and seeing white material in her hair.
Pediatricians honor Fauci at annual meeting
WASHINGTON — The American Academy of Pediatrics on Monday named Anthony S. Fauci, MD, FAAP, an honorary fellow for what it called his “decades of distinguished leadership, dedication, wisdom and service to children and families.”
Survivors of pediatric, young adult melanoma face higher risk for second primary cancer
Survivors of cutaneous melanoma, especially those diagnosed at a young age, were at an increased risk for secondary primary cancers compared with the general population, according to a study.
Study: Important to weigh berdazimer gel benefits vs. risks in molluscum contagiosum
Berdazimer gel benefits and risks should be considered when contemplating its usage for the treatment of molluscum contagiosum, according to a study.
Opzelura effective, well tolerated in children aged at least 2 years with atopic dermatitis
Opzelura achieved significant efficacy for the treatment of atopic dermatitis in children aged as young as 2 years, Incyte announced in a press release.
Coacillium solution sustains adolescent alopecia areata improvement post-treatment
Coacillium solution 22.25% improved moderate to severe alopecia in children and adolescents while retaining results post-treatment, according to a study presented at the European Academy of Dermatology and Venereology 2023 Congress.
Phase 3 results show Vtama rapidly reduces itch in children, adults with atopic dermatitis
Dermavant Sciences has announced new “highly favorable” phase 3 pruritus data for Vtama cream for the treatment of moderate to severe atopic dermatitis in adults and children aged as young as 2 years, according to a press release.
Mucocutaneous manifestations may signal COVID-induced inflammatory disease in children
NEW YORK — Children that contracted COVID-19 are at risk for developing multisystem inflammatory syndrome, which can present cutaneously, according to a poster presentation here.
-
Headline News
A potential new paradigm for treating acute migraine: Timolol nasal spray
November 15, 20245 min read -
Headline News
AI-enabled video of skin on face, hands may detect high blood pressure, diabetes
November 15, 20242 min read -
Headline News
‘Troubling’ data show lack of awareness about lung cancer screening
November 15, 20242 min read
-
Headline News
A potential new paradigm for treating acute migraine: Timolol nasal spray
November 15, 20245 min read -
Headline News
AI-enabled video of skin on face, hands may detect high blood pressure, diabetes
November 15, 20242 min read -
Headline News
‘Troubling’ data show lack of awareness about lung cancer screening
November 15, 20242 min read